Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02311400 · ClinicalTrials.gov registry record
Self-Affirmation, Emotion, and Alcohol Consumption
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 690
- Enrollment target
NCT02311400: Completed study, sponsored by National Cancer Institute (NCI).
NCT02311400 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 690 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02311400 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 690 participants
- Enrollment target
Study Summary
Background: \- People respond differently to life events and how those events make them feel. They also respond differently to information about the how their actions affect their lives and health. Researchers want to learn more about these differences. In this study, researchers will look at how people respond to an event in their life. Researchers will also look at how people respond to information about how their actions can affect their health. Objective: \- To see how people respond differently to life events and information about alcohol and breast cancer. Eligibility: \- Women 18 and older who have never been diagnosed with cancer and who drank 5 or more alcoholic drinks in the past week. Design: * This study will take place online. * Participants will be randomly assigned to 1 of 10 groups. * Researchers will ask participants to take part in 2 small studies, 1 about Life Events and 1 about Alcohol and Breast Cancer. * In the Life Events study, participants will write briefly about a time they felt very happy, fearful, angry, or surprised, or they will write about a room in their house. Then they will answer questions about that event. They also will write about a value that is or is not important to them. * In the Alcohol and Breast Cancer study, participants will read a health message about the link between alcohol and breast cancer. Then they will answer questions about what they read and give their thoughts about alcohol and breast cancer. * Both studies should take about 30 minutes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 690 participants |
| Start Date | 2014-11-19 |
| Est. Completion | 2016-09-29 |
What the finished NCT02311400 record still lists
NCT02311400 is an observational study that tracks outcomes without assigning an intervention. The registered 690 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02311400 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02311400 about?
NCT02311400 is a clinical study titled "Self-Affirmation, Emotion, and Alcohol Consumption". Background: \- People respond differently to life events and how those events make them feel. They also respond differently to information about the how their actions affect their lives and health. Researchers want to learn more about these differences. In this study, researchers will look at how p...
What is the current status of trial NCT02311400?
This trial is currently completed. The enrollment target is 690 participants. The study started on 2014-11-19. Estimated completion is 2016-09-29.
Who is sponsoring clinical trial NCT02311400?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00532051 · 690 participants
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
- NCT05184335 · 690 participants · Phase 3
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- NCT07221149 · 690 participants · Phase 2
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- NCT07382167 · 692 participants · Phase 3
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI